Clinical trial begins for a malaria vaccine

According to The Washington Business Journal, Sanaria will begin its first human clinical trials for a malaria vaccine. The new vaccine hosts a weakened version of the entire malaria parasite. It will be tested on 104 healthy volunteers. Read the full story here.